CUMYL-CH-MEGACLONE (CUMYL-CHMGACLONE, SGT-270) is a
gamma-carboline based
synthetic cannabinoid
Synthetic cannabinoids are a class of designer drug molecules that bind to the same receptors to which cannabinoids (THC, CBD and many others) in cannabis plants attach. These novel psychoactive substances should not be confused with synthetic ...
receptor agonist that has been sold as a
designer drug, first being identified in Hungary in December 2018.
See also
*
5F-CUMYL-PEGACLONE
5F-CUMYL-PEGACLONE (5F-SGT-151, SGT-269) is a gamma-carboline based synthetic cannabinoid that has been sold as a designer drug, first being identified in Germany in 2017. It acts as a potent full agonist of the CB1 receptor. It appears to be ...
*
CUMYL-5F-P7AICA
5F-CUMYL-P7AICA (also known as CUMYL-5F-P7AICA or SGT-263) is a pyrrolo ,3-byridine-3-carboxamide based synthetic cannabinoid that has been sold as a designer drug. It was first identified by the EMCDDA in February 2015.
See also
* 5F-A-P7AIC ...
*
CUMYL-CB-MEGACLONE
CUMYL-CB-MEGACLONE (CUMYL-CBMGACLONE, SGT-273) is a gamma-carboline based synthetic cannabinoid receptor agonist that has been sold as a designer drug, first being identified in Hungary in April 2020.
See also
* 5F-CUMYL-PEGACLONE
* CUMYL-5F ...
*
CUMYL-BC-HPMEGACLONE-221
*
CUMYL-CBMINACA
CUMYL-CBMINACA (SGT-277) is an indazole-3-carboxamide based synthetic cannabinoid receptor agonist that has been sold as a designer drug, first being identified in Germany in February 2020. It is illegal in Finland.
See also
* CUMYL-CBMICA
* ...
*
CUMYL-THPINACA
CUMYL-THPINACA (also known as SGT-42) is an indazole-3-carboxamide based synthetic cannabinoid. CUMYL-THPINACA acts as a potent agonist for the cannabinoid receptors, with approximately 6x selectivity for CB1, having an EC50 of 0.1nM for human ...
References
Cannabinoids
Designer drugs
Gamma-Carbolines
{{cannabinoid-stub